The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain.
The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes [EASD].
In 2013, Silvia Vilares Conde and her research group described that the carotid body, a paired organ that is located in the bifurcation of the common carotid artery and that is classically defined as an oxygen sensor, regulates peripheral insulin sensitivity and that its dysfunction is involved in the development of metabolic diseases.
This first study and others afterwards performed by her group in diabetic rats showed that the bilateral resection of the carotid sinus nerve, and therefore the abolishment of the connection between the carotid body and the brain, restore insulin sensitivity and glucose tolerance. Although efficient this surgical irreversible approach has disadvantages, since the carotid body possess other physiological functions as the response to the lack of oxygen (hypoxia) or the adaptation to exercise. Silvia Conde’s team also described that the carotid body is over-activated in animal models of type 2 diabetes, suggesting that decreasing the activity of the organ could be a good therapeutic strategy.
From the partnership with Galvani Bioelectronics (former Glaxo Smith Kline Bioelectronics), the opportunity to electrically modulate the carotid sinus nerve come up. In fact, this work demonstrated that is possible to maintain glucose homeostasis in animals in which electrodes have been implanted in the carotid sinus nerve and submitted to electrical modulation, without significant adverse effects. It has also been demonstrated that the electrical modulation is reversible. Silvia Conde notes that “this work opens the door to the development of a new therapeutic for type 2 diabetes that will provide a long-term management of the disease with negligible adverse effects and interference with daily activities”.
Type 2 diabetes is characterized by insulin resistance and by increased hepatic glucose production that culminates in hyperglycemia. Although a lot of efforts have been performed until the date none therapeutic induce long-term glycaemia control, being expected for the next decades a huge increase in the prevalence of the disease. Thus, this work gives hope to patients with metabolic diseases, as it brings a new approach for the management of type 2 diabetes.
Learn more: Electronic modulation of carotid sinus nerve can be used as a treatment for type 2 diabetes in rats
The Latest on: Type 2 diabetes
[google_news title=”” keyword=”type 2 diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Semaglutide v. tirzepatide: What to know about popular weight loss and diabetes drugs like Ozempicon April 27, 2024 at 4:00 am
Medications like Ozempic and Mounjaro have revolutionized the treatment of Type 2 diabetes and obesity — and they have grown in popularity as well.
- Type 2 diabetes may increase risk of extracranial large artery disease: Lanceton April 26, 2024 at 9:00 pm
A recent comprehensive study published in The Lancet Regional Health - Europe identified a significant decline in the incidence of peripheral arterial complications among the individuals with ...
- This Type 2 Diabetes Food List Makes Grocery Shopping So Much Easieron April 26, 2024 at 4:00 am
Getting a type 2 diabetes diagnosis can feel overwhelming, and it may seem difficult to nail down the best healthy foods to properly fuel your body and keep your blood sugar stable. But fear ...
- Food additive emulsifiers linked to increased risk of type 2 diabeteson April 25, 2024 at 10:19 pm
Study found a link between consuming certain food emulsifiers and a higher risk of type 2 diabetes. Emulsifiers are common in processed foods and may disrupt gut health, potentially leading to ...
- Lung problems ‘should now be seen as complication of type 2 diabetes’on April 25, 2024 at 5:30 pm
Lung problems should now be seen as a potential complication of type 2 diabetes, a charity has warned. Diabetes UK said new research shows lung disorders can be a direct complication of the condition, ...
- Intensive blood pressure treatment may help some middle-aged women with type 2 diabetes, early-onset hypertensionon April 25, 2024 at 10:30 am
Investigators in the Smidt Heart Institute at Cedars-Sinai and colleagues report that women with type 2 diabetes diagnosed with hypertension before age 50 may benefit from intensive blood pressure ...
- Genetics predict type 2 diabetes risk and disparities in childhood cancer survivorson April 24, 2024 at 11:50 am
Survivors of childhood cancer are at increased risk for cardiovascular disease, for which a risk factor is their greater prevalence of type 2 diabetes, with a disproportionate impact on those of ...
- Emulsifiers in processed foods may be linked to increased risk of type 2 diabeteson April 24, 2024 at 9:51 am
For the first time worldwide, a team of researchers in France has studied the relationships between the dietary intakes of emulsifiers, assessed over a follow-up period of maximum 14 years, and the ...
- Does Alcohol Increase Your Risk of Type 2 Diabetes?on April 24, 2024 at 8:45 am
Alcohol gets a bad rap for a lot of reasons, but does it really raise your risk of diabetes? Nearly 1 in every 10 Americans develops diabetes, most of which is type 2 diabetes. Risk factors for type 2 ...
- Updates in Managing Elderly Patients With Type 2 Diabeteson April 23, 2024 at 5:00 pm
Lyse Bordier, MD, an endocrinologist and metabolic diseases specialist at Bégin Military Teaching Hospital in Saint-Mandé, France, discussed these topics at the Francophone Diabetes Society Congress.
via Google News and Bing News